Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Reference:GBR Clinical investigations of medical devices – compiling a submission to MHRA May 2021 2.-002: Difference between revisions

From GxPlex

Jump to: navigation, search
m 1 revision imported
imported>GxPlexBot
Import from GxPlex Excel
Line 4: Line 4:
|RefDocPart=2.
|RefDocPart=2.
|RefLanguage=EN
|RefLanguage=EN
|RefTagsEN=
|RefTags=TAG-00203-Cli-lin ++ TAG-00046-Ser-sSc ++ TAG-00212-Inc-nis ++ TAG-00340-Req-nfo ++ TAG-00155-Med-Med
|RefTagsOriginal=
|RefModule=5
|RefTagsFR=
|RefUnit=5.3.6
}}
}}


Line 14: Line 14:
|-
|-
! colspan="2" class="gplx-infobox-header" | Reference Details
! colspan="2" class="gplx-infobox-header" | Reference Details
|-
! Module
| Module 5 — Unit 5.3.6
|-
|-
! Scope
! Scope
Line 30: Line 33:
|  
|  
|-
|-
! Tags (EN)
! Tags
|  
| [[Glossary:TAG-00203-Cli-lin|Investigation plan]], [[Glossary:TAG-00046-Ser-sSc|Serious adverse event]], [[Glossary:TAG-00212-Inc-nis|Incident]], [[Glossary:TAG-00340-Req-nfo|Requirements]], [[Glossary:TAG-00155-Med-Med|Medical device]]
|-
! Tags (original language)
|  
|-
! Tags (FR)
|  
|-
|-
! Comment
! Comment

Revision as of 17:29, 15 July 2026



Document information
Reference GBR Clinical investigations of medical devices –

compiling a submission to MHRA May 2021

Validity area GBR
Scope(s) MD
Document name Clinical investigations of medical devices –

compiling a submission to MHRA

Version / Revision May 2021
Status Current
Document type Official recommendation
Language(s) EN
Description Guidance on legislation

Clinical investigations of medical devices – compiling a submission to MHRA

Official source Official link
Restricted access No
Submitted by Florian Adragna
Contributors


Reference Details
Module Module 5 — Unit 5.3.6
Scope MD
Document part 2.
Language EN
Original entry by Florian Adragna
Contributors
Tags Investigation plan, Serious adverse event, Incident, Requirements, Medical device
Comment Repeated entry: 5.2.4 ++ 5.3.6

CIP content: SAE recording and reporting procedures (repeated)

Content

2. Clinical Investigation Plan [….] Description of procedures and details of data to record and report serious adverse events and adverse device related incidents (in line with requirements in MEDDEV 2.7/3 or MDCG 2020-10/1). […]